Unknown

Dataset Information

Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson's Disease.


ABSTRACT: The discovery of the D3 receptor (D3R) subtypes of dopamine (DA) has generated an understandable increase in interest in the field of neurological diseases, especially Parkinson's disease (PD). Indeed, although DA replacement therapy with l-DOPA has provided an effective treatment for patients with PD, it is responsible for invalidating abnormal involuntary movements, known as L-DOPA-induced dyskinesia, which constitutes a serious limitation of the use of this therapy. Of particular interest is the finding that chronic l-DOPA treatment can trigger the expression of D1R-D3R heteromeric interactions in the dorsal striatum. The D3R is expressed in various tissues of the central nervous system, including the striatum. Compelling research has focused on striatal D3Rs in the context of PD and mo

SUBMITTER: Chagraoui A 

PROVIDER: S-EPMC8961531 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature